吸入芳香疗法用于治疗并发性失眠:一个系统的审查和元分析
Hu-Bo Chen1, Yi-Dan Zhang1, Yang Qin1
1College of Basic Medicine, Naval Medical University, Shanghai, China.
Frontiers in psychiatry
|April 15, 2025
概括
吸入芳香疗法有效地减少了并发性失眠,焦虑和抑郁症的症状. 作为一种补充疗法,虽然安全和有益,但需要进一步进行高质量的试验,以解决方法学的局限性.
科学领域:
- 综合医学是一个整体的医学.
- 补充疗法 补充疗法
- 睡眠医学 睡眠医学
背景情况:
- 伴随性失眠症显著影响患者的健康和治疗结果.
- 对于伴随性失眠的现有治疗方法往往具有局限性或副作用.
- 芳香疗法为管理睡眠障碍提供了一个潜在的非药物治疗方法.
研究的目的:
- 系统地评估吸入芳香疗法在治疗伴随性失眠的临床疗效.
- 提供支持芳香疗法作为失眠补充治疗的经验证据.
主要方法:
- 对随机对照试验进行了元分析.
- 搜索的主要数据库 (PubMed,科学网,CNKI,万芳,VIP) 截至2023年8月.
- 使用RevMan 5.3软件进行数据分析.
主要成果:
- 包括27篇与2072名患者发表的论文.
- 吸入芳香疗法显著改善了失眠症状 (MD -2.90,p<0.00001).
- 还减少了焦虑 (MD -3.97,p<0.0001) 和抑郁 (MD -9.58,p=0.0007).
结论:
- 吸入芳香疗法在改善伴随疾病患者的睡眠质量方面显示出安全性和有效性.
- 它显示出作为一种不可或缺的补充疗法的承诺.
- 需要高质量的试验来证实由于研究局限性的发现 (例如,缺乏盲目化,纯度测试).
相关概念视频
Management of Insomnia
220
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
220
Insomnia
75
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
75
Sedatives and Hypnotics Drugs: Miscellaneous Agents
129
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
129
CNS Depressants: Barbiturates and Benzodiazepines
180
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
180
Sedatives and Hypnotics: Overview
236
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
236
Inhalational Anesthetics: Overview
137
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
137


